These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25927573)

  • 21. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
    Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
    AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
    Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
    Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.
    Klimas J; Dong H; Fairbairn N; Socías E; Barrios R; Wood E; Kerr T; Montaner J; Milloy MJ
    Addict Sci Clin Pract; 2018 Feb; 13(1):3. PubMed ID: 29409539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users.
    Kerr T; Marshall BD; Milloy MJ; Zhang R; Guillemi S; Montaner JS; Wood E
    Drug Alcohol Depend; 2012 Jul; 124(1-2):108-12. PubMed ID: 22245312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
    Kapadia F; Vlahov D; Wu Y; Cohen MH; Greenblatt RM; Howard AA; Cook JA; Goparaju L; Golub E; Richardson J; Wilson TE
    Am J Drug Alcohol Abuse; 2008; 34(2):161-70. PubMed ID: 18293232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users.
    Palepu A; Milloy MJ; Kerr T; Zhang R; Wood E
    J Urban Health; 2011 Jun; 88(3):545-55. PubMed ID: 21409604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting.
    Slawson G; Milloy MJ; Balneaves L; Simo A; Guillemi S; Hogg R; Montaner J; Wood E; Kerr T
    AIDS Behav; 2015 Jan; 19(1):120-7. PubMed ID: 25012624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Antiretroviral Adherence Self-efficacy Among People Living With HIV/AIDS in a Canadian Setting.
    Lee WK; Milloy MJS; Nosova E; Walsh J; Kerr T
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):103-109. PubMed ID: 30300214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
    Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
    HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort.
    Braitstein P; Justice A; Bangsberg DR; Yip B; Alfonso V; Schechter MT; Hogg RS; Montaner JS
    AIDS; 2006 Feb; 20(3):323-31. PubMed ID: 16439865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: A longitudinal analysis.
    Ickowicz S; Wood E; Dong H; Nguyen P; Small W; Kerr T; Montaner JSG; Milloy MJ
    Drug Alcohol Depend; 2017 Nov; 180():33-38. PubMed ID: 28865390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals.
    Shuper PA; Joharchi N; Irving H; Fletcher D; Kovacs C; Loutfy M; Walmsley SL; Wong DK; Rehm J
    AIDS Care; 2016 Aug; 28(8):954-62. PubMed ID: 26971360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill.
    Delgado J; Heath KV; Yip B; Marion S; Alfonso V; Montaner JS; O'Shaughnessy MV; Hogg RS
    Antivir Ther; 2003 Oct; 8(5):471-8. PubMed ID: 14640395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longer duration of homelessness is associated with a lower likelihood of non-detectable plasma HIV-1 RNA viral load among people who use illicit drugs in a Canadian setting.
    Loh J; Kennedy MC; Wood E; Kerr T; Marshall B; Parashar S; Montaner J; Milloy MJ
    AIDS Care; 2016 Nov; 28(11):1448-54. PubMed ID: 27248328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia.
    Chan PY; Joseph MA; Des Jarlais DC; Uusküla A
    Int J STD AIDS; 2018 Jan; 29(1):13-22. PubMed ID: 28618981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.
    Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ
    Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting.
    Werb D; Milloy MJ; Kerr T; Zhang R; Montaner J; Wood E
    AIDS Behav; 2013 Jan; 17(1):68-73. PubMed ID: 22249956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.